Intravitreal dexamethasone implant for macular edema following uncomplicated phacoemulsification

European Journal of Ophthalmology

Volumn 24, Issue 3, 2014, Pages 387-391

  Furino, Claudio ^a   Boscia, Francesco ^a   Recchimurzo, Nicola ^a   Sborgia, Carlo ^a   Alessio, Giovanni ^a  

^a POLICLINICO   (Italy)

Author keywords

Dexamethasone; Intravitreal implant; Irvine gass syndrome; Macular edema; Ozurdex

Indexed keywords

DEXAMETHASONE;

ARTICLE; CENTRAL RETINAL THICKNESS; CLINICAL ARTICLE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; INTRAVITREAL IMPLANT; PHACOEMULSIFICATION; PRIORITY JOURNAL; RETINA MACULA EDEMA; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY;

ADULT; AGED; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; LENS IMPLANTATION, INTRAOCULAR; LENSES, INTRAOCULAR; MACULAR EDEMA; MALE; MIDDLE AGED; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VITREOUS BODY;

EID: 84899641127     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/ejo.5000375     Document Type: Article

References (18)

1. Irvine SR. A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol 1953;36:599-619.
2. Drolsum L, Haaskjold E. Causes of decreased visual acuity after cataract extraction. J Cataract Refract Surg 1995;21:59-63.
3. Wright PL, Wilkinson CP, Balyeat HD, Popham J, Reinke M. Angiographic cystoid macular edema after posterior chamber lens implantation. Arch Ophthalmol 1988;106:740-4.
4. Henderson BA, Kim JY, Ament CS, Ferrufino-Ponce ZK, Grabowska A, Cremers SL. Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment. J Cataract Refract Surg 2007;33:1550-8.
5. Williams GA, Haller JA, Kuppermann BD, et al. Dexamethasone DDS Phase II Study Group. Dexamethasone posteriorsegment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol 2009;147:1048-54.
6. Shelsta HN, Jampol LM. Pharmacologic therapy of pseudophakic cystoid macular edema: 2010 update. Retina 2011;31:4-12.
7. Sivaprasad S, Bunce C, Wormald R. Non-steroidal antiinflammatory agents for cystoid macular oedema following cataract surgery: a systematic review. Br J Ophthalmol 2005;89:1420-2.
8. Leopold IH. Nonsteroidal and steroidal anti-inflammatory agents. In: Sears ML, Tarkkanen A, eds. Surgical Pharmacology of the Eye. New York: Raven; 1985:83-133.
9. Pagano G, Bruno A, Cavallo-Perin P, Cesco L, Imbimbo B. Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasone. Arch Intern Med 1989;149:1098-101.
10. Robinson BH, Mattingly D, Cope CL. Adrenal function after prolonged corticosteroid therapy. Br Med J 1962;1:1579-84.
11. Saag KG. Glucocorticoid-induced osteoporosis. Endocrinol Metab Clin North Am 2003;32:135-57.
12. Stanbury RM, Graham EM. Systemic corticosteroid therapy: side effects and their management. Br J Ophthalmol 1998;82:704-8.
13. Weijtens O, Schoemaker RC, Cohen AF, et al. Dexamethasone concentration in vitreous and serum after oral administration. Am J Ophthalmol 1998;125:673-9.
14. Weijtens O, van der Sluijs FA, Schoemaker RC, et al. Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection. Am J Ophthalmol 1997;123:358-63.
15. Weijtens O, Feron EJ, Schoemaker RC, et al. High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am J Ophthalmol 1999;128:192-7.
16. Weijtens O, Schoemaker RC, Romijn FP, Cohen AF, Lentjes EG, van Meurs JC. Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate. Ophthalmology 2002;109: 1887-91.
17. Goldfien A. Adrenocorticosteroids and adrenocortical antagonists. In: Katzung BG, ed. Basic and Clinical Pharmacology, 6th ed. London: Prentice Hall International; 1995: 592-607.
18. Dutra Medeiros M, Navarro R, Garcia-Arumi J, et al. Dexamethasone intravitreal implant for treatment of patients with recalcitrant macular edema resulting from Irvine-Gass syndrome. Invest Ophthalmol Vis Sci 2013;54:3320-4.